What is the maximum recommended dose of gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The maximum recommended dose of gabapentin is 3600 mg/day. This dose is based on the most recent and highest quality evidence available, which recommends gabapentin 900-3600 mg/day for the treatment of painful diabetic peripheral neuropathy 1.

Key Considerations

  • The dose should be divided into three equal doses for adults with normal renal function.
  • Patients should start at a lower dose and gradually increase over several days or weeks to reduce side effects.
  • Dose adjustments are necessary for patients with kidney impairment, with lower maximum doses recommended based on creatinine clearance.

Mechanism and Side Effects

  • Gabapentin works by binding to voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.
  • Common side effects include dizziness, drowsiness, and peripheral edema, which may be minimized by gradual titration.

Discontinuation

  • Patients should not abruptly discontinue gabapentin as this may precipitate withdrawal symptoms or seizures; instead, the medication should be tapered gradually over at least one week under medical supervision.

Clinical Context

  • The recommended dose may vary depending on the specific condition being treated, such as epilepsy, postherpetic neuralgia, or neuropathic pain.
  • It is essential to monitor patients for potential side effects and adjust the dose accordingly to minimize adverse effects while maximizing therapeutic benefits.

From the FDA Drug Label

Dosages up to 2400 mg/day have been well tolerated in long-term clinical studies Doses of 3600 mg/day have also been administered to a small number of patients for a relatively short duration, and have been well tolerated. The maximum recommended dose of gabapentin is 3600 mg/day.

  • The dose can be titrated up as needed for pain relief to a dose of 1800 mg/day (600 mg three times a day) for postherpetic neuralgia.
  • For epilepsy with partial onset seizures, the recommended maintenance dose is 300 mg to 600 mg three times a day (up to 2400 mg/day have been well tolerated) 2.

From the Research

Maximum Recommended Dose of Gabapentin

  • The maximum recommended dose of gabapentin varies depending on the patient and the condition being treated 3, 4, 5, 6, 7.
  • According to a study published in 2003, the maximum maintenance dosage of gabapentin is 3600 mg/d, with some patients tolerating doses up to this level without an increase in adverse reactions 3.
  • Another study published in 1999 suggests that gabapentin dosing must be optimized on an individual basis to achieve an adequate trial of the drug and obtain the best seizure control, with no specific maximum dose recommended 4.
  • A study published in 1999 reported a mean maintenance dose of gabapentin of 1600 mg/day, with a maximum dose of 2400 mg/day 5.
  • Overall, the maximum recommended dose of gabapentin appears to be around 3600 mg/d, although individual patients may require higher or lower doses depending on their specific needs and response to treatment 3, 4, 5, 6, 7.

Dosage Recommendations for Specific Patient Populations

  • For adult patients, gabapentin may be initiated at a dosage of 900 mg/d and titrated to maintenance dosages of 3600 mg/d or more 3.
  • For children, gabapentin may be used at doses of 23 to 78 mg/kg per day 3.
  • For older patients with recently diagnosed seizures, gabapentin may be considered as a first-line treatment option 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin dosing in the treatment of epilepsy.

Clinical therapeutics, 2003

Research

Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.